Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Mollard is active.

Publication


Featured researches published by Paul Mollard.


Bioorganic & Medicinal Chemistry Letters | 2011

α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging

William D. Shrader; Akiko Amagata; Adam Barnes; Gregory M. Enns; Andrew W. Hinman; Orion D. Jankowski; Viktoria Kheifets; Ryo Komatsuzaki; Paul Mollard; Katsuyuki Murase; Alfredo A. Sadun; Martin Thoolen; Kieron E. Wesson; Guy M. Miller

We report that α-tocotrienol quinone (ATQ3) is a metabolite of α-tocotrienol, and that ATQ3 is a potent cellular protectant against oxidative stress and aging. ATQ3 is orally bioavailable, crosses the blood-brain barrier, and has demonstrated clinical response in inherited mitochondrial disease in open label studies. ATQ3 activity is dependent upon reversible 2e-redox-cycling. ATQ3 may represent a broader class of unappreciated dietary-derived phytomolecular redox motifs that digitally encode biochemical data using redox state as a means to sense and transfer information essential for cellular function.


Bioorganic & Medicinal Chemistry Letters | 2012

Towards a modern definition of vitamin E-evidence for a quinone hypothesis.

William D. Shrader; Akiko Amagata; Adam Barnes; Andrew W. Hinman; Orion D. Jankowski; Viktoria Kheifets; Ryo Komatsuzaki; Paul Mollard; Katsuyuki Murase; Patrice Rioux; Kieron E. Wesson; Guy M. Miller

We report on the synthesis, biological and pharmacological activity of the tocoquinone natural product, α-tocopherol quinone (ATQ); an oxidative metabolite of α-tocopherol. ATQ is a potent cellular protectant against oxidative stress, whose biological activity is dependent upon its ability to undergo reversible two-electron redox cycling. ATQ is orally bioavailable, with a favorable pharmacokinetic profile and has demonstrated a beneficial clinical response in patients with Friedreichs ataxia. ATQ is a member of a broader class of vitamin E derived quinone metabolites which may be ascribable in whole or in part to the activity of vitamin E.


Archive | 2007

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

Guy M. Miller; Sidney M. Hecht; Orion D. Jankowski; Kieron E. Wesson; Paul Mollard


Archive | 2008

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

Orion D. Jankowski; Kieron E. Wesson; Paul Mollard; William D. Shrader


Archive | 2009

2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES

Andrew W. Hinman; Kieron E. Wesson; Orion D. Jankowski; Paul Mollard; William D. Shrader; Christopher R. Cornell


Archive | 2007

PHENOL AND 1,4-BENZOQUINONE DERIVATIVES FOR USE IN THE TREATMENT OF MITOCHONDRIAL DISEASES

Guy M. Miller; Sidney M. Hecht; Orion D. Jankowski; Kieron E. Wesson; Paul Mollard


Archive | 2017

POLYMORPHIC AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE

Paul Mollard; Christopher R. Cornell; Kieron E. Wesson; Peter Giannousis; Shazad Suchit; Mahmoud Mirmehrabi


Archive | 2015

Methods for chiral resolution of trolox

Guy M. Miller; Paul Mollard; William D. Shrader; Viktoria Kheifets; Jeffrey K. Trimmer


Archive | 2014

2-SUBSTITUTION-p-QUINONE DERIVATIVE FOR TREATMENT OF OXIDATIVE STRESS DISEASE

Andrew W Hiinman; Kieron E. Wesson; Orion D. Jankowski; Paul Mollard; William D. Shrader; Christpher R Cornell


Archive | 2014

4-(p-QUINOLYL)-2-HYDROXYBUTANE AMIDE DERIVATIVE FOR TREATMENT OF MITOCHONDRIAL DISEASE

Orion D. Jankowski; Kieron E. Wesson; Paul Mollard; William D. Shrader

Collaboration


Dive into the Paul Mollard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alfredo A. Sadun

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge